drugset / Trial / NCT04278872
Phase 2 Study of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms
RandomizedParallel-groupDouble-blindTreatment
Summary
This study evaluates the efficacy, safety, tolerability, and pharmacokinetics of once daily SJX-653 in postmenopausal women with moderate to severe VMS.
Timeline
- Start
- 2020-11-09
- Primary completion
- 2021-02-12
- Completion
- 2021-04-07
Outcome
Outcome not reported
Stopped: “The study was terminated early as the goal of determining a safe and efficacious dose for further development for the treatment of VMS was not met”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SJX-653 | Unknown | — | Oral |
Indications
No indication recorded.